Personal information

No personal information available

Activities

Collapse all

Works (3)

Use of Sensitivity Analyses to Assess Uncontrolled Confounding from Unmeasured Variables in Observational, Active Comparator Pharmacoepidemiologic Studies: A Systematic Review

2024-07-31 | Other
DOI: 10.1093/aje/kwae234
Contributors: Chase Latour; Megan Delgado; I-Hsuan Su; Catherine Wiener; Clement Acheampong; Charles Poole; Jessie K. Edwards; Kenneth Quinto; Til Stürmer; Jennifer Lund et al.
Source: check_circle
Crossref

Categorization of COVID‐19 severity to determine mortality risk

Pharmacoepidemiology and Drug Safety
2022-07 | Journal article
DOI: 10.1002/pds.5436
Contributors: Elizabeth M. Garry; Andrew R. Weckstein; Kenneth Quinto; Marie C. Bradley; Tamar Lasky; Aloka Chakravarty; Sandy Leonard; Sarah E. Vititoe; Imaani J. Easthausen; Jeremy A. Rassen et al.
Source: check_circle
Crossref

Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety

JNCI Cancer Spectrum
2022-07-01 | Journal article
DOI: 10.1093/jncics/pkac049
Contributors: David Merola; Sebastian Schneeweiss; Sushama K Sreedhara; Luke E Zabotka; Kenneth Quinto; John Concato; Shirley V Wang
Source: check_circle
Crossref
How many people are using ORCID?